These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3325012)

  • 1. Epidemiology and prevention of invasive Haemophilus influenzae type b infection.
    Gilbert GL
    Aust Paediatr J; 1987 Dec; 23(6):323-7. PubMed ID: 3325012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampicin prophylaxis for throat carriage of Haemophilus influenzae type b in patients with invasive disease and their contacts.
    Gilbert GL; MacInnes SJ; Guise IA
    BMJ; 1991 Jun; 302(6790):1432-5. PubMed ID: 2070109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilus influenzae type b infections in day care attendees: implications for management.
    Daum RS; Granoff DM; Gilsdorf J; Murphy T; Osterholm MT
    Rev Infect Dis; 1986; 8(4):558-67. PubMed ID: 3529311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
    Hay JW; Daum RS
    Pediatrics; 1987 Sep; 80(3):319-29. PubMed ID: 3114708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak.
    Granoff DM; McKinney T; Boies EG; Steele NP; Oldfather J; Pandey JP; Suarez BK
    Pediatrics; 1986 Mar; 77(3):289-95. PubMed ID: 3485275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Type B Haemophilus influenzae infections: epidemiology, vaccination, chemoprophylaxis].
    Noack R; Padelt H
    Kinderarztl Prax; 1991 Dec; 59(12):365-7. PubMed ID: 1774852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive Haemophilus influenzae type B infections: a continuing challenge.
    Janai H; Stutman HR; Marks MI
    Am J Infect Control; 1990 Jun; 18(3):160-6. PubMed ID: 2194406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin alone and in combination with trimethoprim in chemoprophylaxis for infections due to Haemophilus influenzae type b.
    Glode MP; Daum RS; Halsey NA; Johansen TL; Goldmann DA; Ambrosino D; Boies E; Granoff DM
    Rev Infect Dis; 1983; 5 Suppl 3():S549-55. PubMed ID: 6605565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of Hemophilus influenzae type b disease.
    Band JD; Fraser DW; Ajello G
    JAMA; 1984 May; 251(18):2381-6. PubMed ID: 6368889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b.
    Shapiro ED; Wald ER
    Pediatrics; 1980 Jul; 66(1):5-8. PubMed ID: 6967587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae disease and immunization in developing countries.
    Funkhouser A; Steinhoff MC; Ward J
    Rev Infect Dis; 1991; 13 Suppl 6():S542-54. PubMed ID: 1862284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Haemophilus influenzae type b infections in day care: a public health perspective.
    Fleming DW; Cochi SL; Hull HF; Helgerson SD; Cundiff DR; Broome CV
    Rev Infect Dis; 1986; 8(4):568-72. PubMed ID: 3529312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type b disease after rifampin prophylaxis in a day care center: possible reasons for its failure.
    Murphy TV; McCracken GH; Moore BS; Gulig PA; Hansen EJ
    Pediatr Infect Dis; 1983; 2(3):193-8. PubMed ID: 6602974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New protection against Haemophilus influenzae type b infections in infants and young children.
    Reece SM
    Nurse Pract; 1991 Nov; 16(11):27, 31-6. PubMed ID: 1766598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.
    Black SB; Shinefield HR
    Pediatr Infect Dis J; 1992 Aug; 11(8):610-3. PubMed ID: 1523069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Fogarty J; Moloney AC; Ramsay ME; Moxon ER
    Pediatr Infect Dis J; 2001 Mar; 20(3):300-5. PubMed ID: 11303834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilus influenzae type B epiglottitis after immunization with HbOC conjugate vaccine.
    Keyser JS; Derkay CS
    Am J Otolaryngol; 1994; 15(6):436-43. PubMed ID: 7872480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive Haemophilus influenzae infections in household contacts of patients with Haemophilus influenzae meningitis and epiglottitis.
    Trollfors B
    Acta Paediatr Scand; 1991; 80(8-9):795-7. PubMed ID: 1957598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreases in invasive Haemophilus influenzae diseases in US Army children, 1984 through 1991.
    Broadhurst LE; Erickson RL; Kelley PW
    JAMA; 1993 Jan; 269(2):227-31. PubMed ID: 8417240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.
    Levine OS; Ortiz E; Contreras R; Lagos R; Vial P; Misraji A; Ferreccio C; Espinoza C; Adlerstein L; Herrera P
    Am J Epidemiol; 1993 Jun; 137(11):1221-8. PubMed ID: 8322763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.